Related Experiment Videos
Antimicrobial resistance in organisms causing diarrheal disease
1Division of Community Health, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka.
Abstract:
Antimicrobial resistance is becoming increasingly important in the treatment of enteric infections, particularly those due to Shigella, Vibrio cholerae, enterotoxigenic Escherichia coli (associated with traveler's diarrhea), and Salmonella typhi. The rate of antimicrobial resistance is highest in the developing world, where the use of antimicrobial drugs is relatively unrestricted. Of greatest immediate concern is the need for an effective, inexpensive antimicrobial that can be used safely as treatment for small children with dysentery due to Shigella, primarily Shigella dysenteriae type 1.
Insights
Antimicrobial resistance is a growing concern for enteric infections like Shigella. Developing nations face the highest rates, necessitating affordable and safe treatments, especially for children with Shigella dysentery.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Antimicrobial resistance (AMR) poses a significant challenge in treating enteric infections.
- High rates of AMR are observed in developing countries due to unrestricted antimicrobial drug use.
- Specific pathogens like Shigella, Vibrio cholerae, enterotoxigenic Escherichia coli, and Salmonella typhi are major concerns.
Purpose of the Study:
- To highlight the increasing importance of antimicrobial resistance in enteric infections.
- To emphasize the urgent need for effective, affordable, and safe antimicrobial treatments.
- To address the critical requirement for treating pediatric dysentery caused by Shigella.
Main Methods:
- Literature review on antimicrobial resistance patterns.
- Analysis of treatment challenges for enteric pathogens.
- Focus on the specific needs for treating Shigella infections in children.
Main Results:
- Antimicrobial resistance is a critical factor in managing enteric infections globally.
- Developing regions exhibit the highest prevalence of antimicrobial resistance.
- There is a pressing need for new antimicrobial agents suitable for pediatric use.
Conclusions:
- Effective and affordable antimicrobial agents are crucial for combating enteric infections, particularly in resource-limited settings.
- Addressing antimicrobial resistance in Shigella, especially Shigella dysenteriae type 1, is a priority for pediatric health.
- Global strategies are needed to manage antimicrobial resistance and ensure access to safe treatments.